Brian Case
Chief Tech/Sci/R&D Officer at KORU MEDICAL SYSTEMS, INC.
Net worth: 280 250 $ as of 30/03/2024
Profile
Brian Case is currently the Chief Technology Officer at KORU Medical Systems, Inc. Prior to his current position, he served as the Vice President-Research & Development at Fresenius Kabi AG from 2006 to 2022.
Mr. Case holds a graduate degree from Rose-Hulman Institute of Technology, Inc. and an undergraduate degree from the University of Illinois.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 23/03/2024 | 118,750 ( 0.26% ) | 280 250 $ | 30/03/2024 |
Brian Case active positions
| Companies | Position | Start |
|---|---|---|
| KORU MEDICAL SYSTEMS, INC. | Chief Tech/Sci/R&D Officer | 17/04/2022 |
Former positions of Brian Case
| Companies | Position | End |
|---|---|---|
Fresenius Kabi AG
 Fresenius Kabi AG Pharmaceuticals: MajorHealth Technology Fresenius Kabi AG manufactures medical devices for therapies. It specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. The firm offers infusion solutions for fluid substitution, blood volume replacement, intravenously administered drugs as well as the respective medical devices for the application, pump systems and infusion management systems. The company was founded in 1999 and is headquartered in Bad Homburg, Germany. | Chief Tech/Sci/R&D Officer | 30/04/2022 |
Training of Brian Case
| Rose-Hulman Institute of Technology, Inc. | Graduate Degree |
| University of Illinois | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| KORU MEDICAL SYSTEMS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Fresenius Kabi AG
Fresenius Kabi AG Pharmaceuticals: MajorHealth Technology Fresenius Kabi AG manufactures medical devices for therapies. It specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. The firm offers infusion solutions for fluid substitution, blood volume replacement, intravenously administered drugs as well as the respective medical devices for the application, pump systems and infusion management systems. The company was founded in 1999 and is headquartered in Bad Homburg, Germany. | Health Technology |
- Stock Market
- Insiders
- Brian Case
